INTEGRA Biosciences Nordic ApS — Credit Rating and Financial Key Figures

CVR number: 43279092
Vallensbækvej 22 A, 2605 Brøndby
kirsten.thuesen@integra-biosciences.com
tel: 20914000

Income statement (kDKK)

20222023
Fiscal period length1212
Net sales
Gross profit- 227.212 905.35
Employee benefit expenses- 772.74-3 631.59
Total depreciation-38.56
EBIT- 999.95- 764.80
Other financial income4.46148.20
Other financial expenses-37.89- 339.59
Pre-tax profit-1 033.38- 956.19
Net earnings-1 033.38- 956.19

Assets (kDKK)

20222023
Intangible assets total
Machinery and equipment159.28
Tangible assets total159.28
Investments total
Long term receivables total
Raw materials and consumables1 177.812 623.84
Inventories total1 177.812 623.84
Current trade debtors85.303 237.74
Prepayments and accrued income46.0930.93
Current other receivables143.42186.95
Short term receivables total274.803 455.62
Cash and bank deposits977.972 385.48
Cash and cash equivalents977.972 385.48
Balance sheet total (assets)2 430.588 624.23

Equity and liabilities (kDKK)

20222023
Share capital40.0040.00
Retained earnings-1 033.38
Profit of the financial year-1 033.38- 956.19
Shareholders equity total- 993.38-1 949.58
Non-current owed to group member8 000.00
Non-current liabilities total8 000.00
Current loans from credit institutions0.97
Current trade creditors14.35204.26
Current owed to group member3 283.72717.04
Other non-interest bearing current liabilities105.901 452.50
Accruals and deferred income20.00199.03
Current liabilities total3 423.962 573.80
Balance sheet total (liabilities)2 430.588 624.23
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.